Related Experiment Videos
[Fumaric acid therapy in psoriasis; a double-blind, placebo-controlled study].
W M Nugteren-Huying1, J G van der Schroeff, J Hermans
1Academisch Ziekenhuis, afd. Dermatologie, Leiden.
Nederlands Tijdschrift Voor Geneeskunde
|December 8, 1990
Summary
Fumaric acid ester therapy, a combination of monoethyl- and dimethylfumarate, significantly improved psoriasis symptoms in a 16-week study. This treatment showed better efficacy than placebo or octylhydrogen fumarate, despite some side effects.
Area of Science:
- Dermatology
- Pharmacology
Background:
- Psoriasis is a chronic inflammatory skin condition affecting numerous individuals worldwide.
- Current treatments for psoriasis have limitations and potential side effects.
- Fumaric acid esters have emerged as a potential therapeutic option.
Purpose of the Study:
- To evaluate the efficacy and safety of fumaric acid ester therapy in patients with psoriasis.
- To compare the therapeutic response of a combination of monoethyl- and dimethylfumarate against placebo and octylhydrogen fumarate.
Main Methods:
- A randomized, double-blind, placebo-controlled study was conducted with 39 psoriasis patients.
- Patients received either fumaric acid ester combination, octylhydrogen fumarate, or placebo for 16 weeks.
- All participants received standardized topical therapy and followed an elimination diet.
Main Results:
- The combination of monoethyl- and dimethylfumarate demonstrated significantly superior therapeutic response compared to placebo and octylhydrogen fumarate.
- Common side effects included flushing, diarrhea, reversible elevated transaminases, lymphocytopenia, and eosinophilia.
- One patient experienced a transient kidney function disturbance.
Conclusions:
- Fumaric acid ester therapy, specifically the combination of monoethyl- and dimethylfumarate, is an effective treatment for psoriasis.
- The therapy offers a viable alternative for psoriasis management, though potential side effects require monitoring.
- Further research may explore optimizing dosage and managing side effects for enhanced patient outcomes.